Parvovirus is one of the most frequently encountered diseases in small animal practice. By attacking rapidly dividing cells in the lymph nodes, intestinal lining and bone marrow, it causes profound immunosuppression, vomiting and haemorrhagic diarrhoea, often leading to life-threatening dehydration. In this Q&A session, Dr Liza le Roux, Technical Manager at Zoetis, provides clinical insights into canine parvovirus (CPV), covering current trends, risk factors and management strategies.

1.  Are dogs or cats more commonly affected? And clinically, how do CPV and FPV differ in presentation, prognosis and outcomes?
   Dogs are more affected than cats. CPV shows rapid, severe gastrointestinal (GI) symptoms such as acute vomiting and bloody diarrhoea. The severity of the clinical presentation is highly variable and dependent on the pup’s seroconversion post-vaccination. Feline parvovirus causes panleukopenia with acute immune suppression. Prognosis is poor for both if untreated, but with cats we often have worse outcomes.
   
2. How effective is vaccination in preventing CPV?
   Vaccination does not equal immunisation. Not all vaccine administrations result in the development of active immunity against CPV, leading to immunisation failures that allow the vaccinated dogs to be exposed to CPV infection and disease.
   
3. Is there a clear seasonality pattern in South Africa? If so, which months tend to show the highest caseload and why?
   Yes, parvo cases usually peak in late winter and early spring (July–October), likely due to increased breeding, more puppies, and immune stress in colder months.
   
4. What are the most reliable early warning signs that a ‘routine gastro case’ may actually be parvo? What red flags should vets never ignore?
   Red flags: sudden lethargy, abdominal pain, profuse vomiting plus bloody diarrhoea, rapid dehydration, hypoglycaemia. The core findings of Schoeman et al regarding prognostic markers in canine parvoviral enteritis remain valid and widely accepted in clinical practice:

• Hypoalbuminaemia is still recognized as a strong negative prognostic indicator.
• Other markers (leucopaenia, lymphopaenia, thrombocytopaenia, hypercortisolaemia, hypothyroxinaemia, elevated c-reactive protein (CRP), tumour necrosis factor, hypocholesterolaemia, hypocitrullinaemia) remain relevant for risk stratification and targeted management.
  
  New research expands on these markers (especially acute-phase proteins and micronutrients), but hypoalbuminaemia and the cited signalment/clinical factors are still considered pivotal for triage and prognosis.

5. Are there any ways to foresee which animals are most at risk before they deteriorate? (eg age, vaccination gaps, breed predispositions, parasite load, nutrition status, stress, overcrowding)
   
   At-risk for parvo: Puppies <6-months old, unvaccinated, those with worm burdens, poor nutrition, high stress, and dense housing. Certain black and tan breeds (Rottweiler, Doberman, German Shepherds) have increased risk.
   
   Most parvo cases are reported in unvaccinated pups, some cases are seen in pups with interrupted vaccination programmes and a few cases even in 16- to 18-month old dogs who missed their one-year booster vaccine. The puppy series of primary vaccination at six-, nine- and 12-weeks followed by the annual booster is the basic standard programme. Missing the annual booster dose at 15-months old, means the vaccination protocol is incomplete.
   
   Failure to fully immunise represents one of the main reasons for CPV continuous circulation throughout the world and may be due to different causes, with persistence of maternal immunity at the time of vaccination, one of the most important reasons. Another important reason is pups with an inadequate immunisation/seroconversion rate, who are then placed in an environment with overwhelming exposure to parvo from which their suboptimal humoral immunity cannot protect them. True non-responders (~1 in 1000 dogs are classified as genetic non-responders), failing to produce detectable antibodies despite multiple vaccine administrations. Lastly, a true vaccine failure (cold chain broken/expired vaccine or compromised product).

6. Which diagnostic approach do you recommend in practice? When is a rapid SNAP test sufficient, and when should PCR or repeat testing be considered?
   
   Veterinary point-of-care enzyme-linked immunosorbent assay (SNAP) tests are a good first step. The rapid canine parvovirus antigen test detects parvoviral antigen shed in the feces. After natural infection, viral shedding typically begins on day three to four post-exposure, often preceding clinical signs. Shedding is most extensive for seven- to 10-days, and CPV-2 is rarely detectable by day 10-12 after infection, corresponding to about five- to seven- days of clinical illness.
   
   Vaccine-associated shedding and a ‘false positive’ result is not usually accompanied by clinical illness. Also, it is detectable during shedding which is most extensive for seven- to 10-days, and rarely detectable after day 12 post-vaccination. If the puppy is showing overt signs of parvovirus (eg vomiting, diarrhoea, lethargy), this strongly suggests active infection rather than vaccine virus shedding in this period. Three-months post vaccination will not be vaccine shedding related.
   
   Polymerase chain reaction/enzyme-linked immunosorbent assay or repeat testing is recommended if clinical suspicion remains with negative tests, or for atypical cases. No recent publication disputes the value of hypoalbuminaemia, leucopaenia, CRP et cetera for early identification and management.

7. What is your recommended triage approach when parvo is suspected? What should be done immediately in the first 30- to 60-minutes after presentation?
   
   Immediate isolation and start with intravenous (IV) fluids, monitor the vitals, sugar[FL1]  and electrolytes, correct hypoglycaemia/hypokalaemia, administer antiemetics, analgesics and antibiotics as needed. Provide early enteral nutrition as soon as vomiting resolves and GI function returns.

8. What are the most common clinical mistakes that lead to poor outcomes? (eg delayed IV fluids, underestimating sepsis risk, poor glucose monitoring)
   
   Pitfalls are delays in fluid resuscitation, neglecting glucose/electrolyte monitoring, underestimating sepsis risk, not reassessing vital parameters and response to treatment every one- to two-hours in the most critical phase. Missing hypoproteinaemia or hypothermia.

9. Can you walk us through your ideal treatment algorithm step-by-step?
   
   • Admission: Isolation, IV access and fluid resuscitation, glucose/electrolyte checks, antiemetic, analgesic and antibiotic support.
   • Daily: Reassess hydration, nutrition, GI symptoms.
   • Discharge: After stable hydration and oral eating for 24- to 48-hours.
     
10. What is your recommended fluid therapy strategy in parvo cases? How do you calculate needs, manage electrolyte losses, and avoid overhydration in small puppies/kittens?
    
    Calculate by weight and deficit. Typically, 90–100ml/kg/day for maintenance plus replacement losses. Use isotonic crystalloid (eg Ringer’s), adjust for hypokalaemia/hypoglycaemia, avoid fluid overload especially in small breeds.

11. How should vets approach antiemetics and GI protectants in your opinion? Which drugs do you prefer, and what combination works best in severe vomiting cases?
    
    First-line antiemetic is maropitant with the addition of metoclopramide/ondansetron if symptoms are severe. GI protectants: Use omeprazole or sucralfate if there is bleeding.

12. Antibiotic use is often debated in parvo. What is your antibiotic protocol and reasoning? Which cases need broad-spectrum coverage, and when do you escalate?
    
    Broad-spectrum antibiotics (eg amoxiclav, cephalosporin) for all confirmed parvo cases due to sepsis risk. Escalate if poor response or suspicion of secondary infections.

13. When and how do you introduce nutrition? Do you favour early enteral feeding, naso-oesophageal tubes, or waiting until vomiting resolves?
    
    Start early enteral feeding as soon as vomiting subsides. Wait if severe GI symptoms persist. Early enteral nutrition is beneficial, as it:

• Stimulates enterocyte regeneration and repair of the gut mucosa.
• Maintains gut motility (reducing risk of ileus).
• Supports the local immune defenses (gut-associated lymphoid tissue).
• Reduces bacterial translocation and risk of sepsis.
• Improves overall prognosis and accelerates recovery.

14. What new treatment pathways or emerging therapies are you excited about? For example, monoclonal antibody therapy, plasma transfusions, interferons, or novel supportive strategies.
    
    Plasma transfusions from recovered dogs, and newer interferons. These are promising but not yet routine.

15. What discharge plan do you recommend to prevent relapse and reinfection? Including home isolation, environmental disinfection, vaccination scheduling, and client compliance tips.
    
    Home isolation for two-weeks, strict environmental cleaning (bleach or parvo-effective products), restarts vaccination as soon as safe, educate owners on hygiene and compliance.

Practice pearls for Vets

1. Early recognition saves lives
   Always consider parvovirus in puppies with sudden lethargy, profuse vomiting, bloody diarrhoea, dehydration, or hypoglycaemia. Prompt recognition and triage within the first 30- to 60-minutes can drastically improve outcomes.
2. Vaccination ≠ immunity
   Not all vaccinated puppies develop full immunity. Ensure puppies complete the primary series (six-, nine-, 12-weeks) and annual boosters. Be aware of maternal antibody interference, interrupted schedules, and rare non-responders when assessing risk.
3. Fluid therapy is critical
   Calculate fluids carefully based on weight, dehydration, and ongoing losses (typically 90–100ml/kg/day). Use isotonic crystalloids, correct electrolytes and glucose, and avoid fluid overload in small breeds or severely debilitated pups. Frequent reassessment is essential².
4. Early enteral nutrition supports recovery
   Introduce feeding as soon as vomiting subsides. Early enteral nutrition maintains gut motility, supports mucosal repair, enhances local immunity, and reduces bacterial translocation, all contributing to faster recovery.
5. Monitor prognostic markers
   Check hypoalbuminaemia, leucopaenia, CRP, and other acute-phase proteins to stratify risk. Use these markers along with clinical signs to guide treatment intensity and triage decisions.

Additional reading

Decaro N, Buonavoglia C, Barrs VR. Canine parvovirus vaccination and immunisation failures: Are we far from disease eradication? Vet Microbiol, 2020 Aug;247:108760. doi: 10.1016/j.vetmic.2020.108760. Epub 2020 Jun 15. PMID: 32768213; PMCID: PMC7295477. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7295477/

Schoeman JP, Goddard A, Leisewitz AL. Biomarkers in canine parvovirus enteritis. N Z Vet J, 2013 Jul;61(4):217-22. doi: 10.1080/00480169.2013.776451. Epub 2013 Mar 12. PMID: 23477413. Available at: https://pubmed.ncbi.nlm.nih.gov/23477413/

---